MENU

ABOS Acumen Pharmaceuticals Forecast, Technical & Fundamental Analysis

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

ABOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ABOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABOS is expected to report earnings to rise 14.45% to -37 cents per share on November 16

Acumen Pharmaceuticals ABOS Stock Earnings Reports
Q3'26
Est.
$-0.38
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.16
Q2'25
Missed
by $0.17
The last earnings report on May 12 showed earnings per share of -33 cents, beating the estimate of -37 cents. With 194.18K shares outstanding, the current market capitalization sits at 211.53M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1210-1220 Washington Street
Phone
+1 617 344-4190
Employees
61
Web
https://www.acumenpharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NPNEX62.800.39
+0.62%
Neuberger Large Cap Value E
THPBX25.810.12
+0.47%
BNY Mellon Balanced Opportunity J
CGRCX32.25N/A
N/A
Invesco Comstock Select C
KTCCX15.23N/A
N/A
DWS Science and Technology C
SBRAX18.44N/A
N/A
Segall Bryant & Hamill All Cap Ret

ABOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CCXI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CCXI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+2.10%
CCXI - ABOS
48%
Loosely correlated
-3.83%
NKTX - ABOS
43%
Loosely correlated
+3.56%
RCKT - ABOS
41%
Loosely correlated
-3.74%
EDIT - ABOS
41%
Loosely correlated
+1.89%
BCYC - ABOS
40%
Loosely correlated
+0.78%
More
Acumen Pharmaceuticals (ABOS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com